Proactive COVID-19 Infection Prevention Measures in a Hyperbaric Oxygen Therapy Center.
infection control, cross infection, HBOT, SARS-CoV-2, corona virus disease 2019
Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China in December 2019 and its subsequent global spread, Taiwan has been combatting this pandemic. COVID-19 is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As SARS-CoV-2 can be transmitted through droplets and aerosols, we cannot ignore the risk of transmission during hyperbaric oxygen therapy (HBOT). Our hyperbaric oxygen therapy center prioritizes preventing the spread of COVID-19 and maintaining operation for the patients during the pandemic. The aim of this article is to share the protocol that we have adopted in our hyperbaric oxygen therapy center to help prevent the spread of COVID-19.
Su-Shin Lee, Shu-Hung Huang, Ching-Tzu Hung, Hsiao-Chen Lee, Jing-Jou Lo, Su-Chen Wang, Hsiu-Ying Lee